The WHO has issued new targets for long-acting injectable TB medicines that could reduce months of daily pills to a single ...
Newswise — Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, with outbreaks continuing to emerge globally and domestically. Rajita Bhavaraju, director of global operations ...
A new study conducted by the World Health Organization (WHO) suggests that in addition to providing significant improvements in public health, investment in the diagnosis and prevention of ...
Health and Me on MSN
TB treatment in 4 months with 3 or fewer injections? WHO pushes for long-acting options
Long-acting injectables are sustained-release medicines administered through intramuscular or subcutaneous injections. They ...
Despite efforts to eliminate the disease, 13 million Americans are living with latent tuberculosis infection, according to the most recent statistics from the National Health and Nutrition Examination ...
WHO’s target regimen profiles cover preventive treatment and treatment for people with TB disease, with separate expectations ...
In marking World Tuberculosis Day, the World Health Organization is calling for action to rid the world of this ancient scourge, which has sickened and killed millions of people throughout the ages.
Guam's experience responding to drug-resistant tuberculosis could help shape national prevention strategies following the ...
Tuberculosis (TB) remains the world's leading cause of death from a single infectious agent. A new study recently published in The Lancet Global Health and supported by the World Health Organization ...
Taking a common antibiotic could more than half the risk of children becoming sick with multidrug resistant tuberculosis (MDR-TB), according to findings presented this week at a conference on lung ...
A 3-month, 12-dose regimen of rifapentine and isoniazid (INH) was less toxic, had better compliance, and showed similar efficacy as 6 months of INH alone in preventing tuberculosis (TB) in people with ...
An ongoing tuberculosis outbreak in the Kansas City metropolitan area straddling Kansas and Missouri has made headlines across the country, a rare feat for an infectious disease too often ignored in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results